Synopsys Inc (SNPS):企業の財務・戦略的SWOT分析

◆英語タイトル:Synopsys Inc (SNPS) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDTC33335FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年3月
◆ページ数:59
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Technology and Communications
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Synopsys Inc (SNPS) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Synopsys Inc (Synopsys) is a provider of electronic design automation (EDA) software and associated services. The company’s product portfolio comprises IC design solutions; verification continuum platform, which offers virtual prototyping, static and formal verification solutions. Synopsys provides a wide range of solutions, including system simulation and modeling, 3D image processing, optical solutions, photonic solutions, system-level solutions, manufacturing solutions, and professional services. It offers intellectual property, system-level design hardware and software products. Synopsys serves artificial intelligence (AI), automotive, internet of things (IoT), cloud computing, and 5G mobile markets. The company has business operations across Americas, Europe and Asia-Pacific. Synopsys is headquartered in Mountain View, California, the US.

Synopsys Inc Key Recent Developments

Oct 19,2020: Synopsys accelerates power electronics system design with virtual prototyping solution

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Synopsys Inc – Key Facts
Synopsys Inc – Key Employees
Synopsys Inc – Key Employee Biographies
Synopsys Inc – Major Products and Services
Synopsys Inc – History
Synopsys Inc – Company Statement
Synopsys Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Synopsys Inc – Business Description
Business Segment: Semiconductor and System Design Segment
Overview
Performance
Business Segment: Software Integrity Segment
Overview
Performance
Geographical Segment: China
Performance
Geographical Segment: Europe
Target Markets
Performance
Geographical Segment: Korea
Performance
Geographical Segment: Other
Performance
Geographical Segment: The US
Performance
R&D Overview
Synopsys Inc – Corporate Strategy
Synopsys Inc – SWOT Analysis
SWOT Analysis – Overview
Synopsys Inc – Strengths
Synopsys Inc – Weaknesses
Synopsys Inc – Opportunities
Synopsys Inc – Threats
Synopsys Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Recent Developments
Oct 19, 2020: Synopsys accelerates power electronics system design with virtual prototyping solution
Section 5 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Synopsys Inc, Key Facts
Synopsys Inc, Key Employees
Synopsys Inc, Key Employee Biographies
Synopsys Inc, Major Products and Services
Synopsys Inc, History
Synopsys Inc, Other Locations
Synopsys Inc, Subsidiaries
Synopsys Inc, Key Competitors
Synopsys Inc, Ratios based on current share price
Synopsys Inc, Annual Ratios
Synopsys Inc, Annual Ratios (Cont...1)
Synopsys Inc, Annual Ratios (Cont...2)
Synopsys Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Synopsys Inc (SNPS):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Seoul City Gas Co Ltd (017390):企業の財務・戦略的SWOT分析
    Seoul City Gas Co Ltd (017390) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Intech Biopharm Ltd (6461):医療機器:M&Aディール及び事業提携情報
    Summary Intech Biopharm Ltd (Intech Biopharm) is a drug developing company that develops drugs for obstructive airway diseases. The company provides marketed products such as single ingredient generics such as Synvent, and Duasma, developed for asthma; and multi-ingredient generic, Synflutide, for a …
  • XuanZhu Pharma Co Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary XuanZhu Pharma Co Ltd (XuanZhu), a subsidiary of Sihuan Pharmaceutical Holdings Group Ltd, is a developer and manufacturer of medicinal products. The company’s products comprise anti-infective drugs apapenem and benapenem; anti-acid drug anaprazole sodium, anti-diabetic drug imigliptin hydro …
  • Fibrocell Science Inc (FCSC):製薬・医療:M&Aディール及び事業提携情報
    Summary Fibrocell Science Inc (Fibrocell Science) is an autologous cell and gene therapy company which discovers and develops therapies for diseases affecting the skin and connective tissue. The company’s product pipeline comprises FCX-007, a lead candidate for the treatment of recessive dystrophic …
  • Virometix AG:製薬・医療:M&Aディール及び事業提携情報
    Summary Virometix AG (Virometix) is a biotechnology company that develops vaccines and immunotherapeutic drugs for the prevention and treatment of infectious and chronic human diseases. The company’s pipeline products include prophylactic and therapeutic vaccines for infectious, respiratory, and onc …
  • OGK-2 (OGKB):企業の財務・戦略的SWOT分析
    OGK-2 (OGKB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pote …
  • Lidds AB (LIDDS):企業の財務・戦略的SWOT分析
    Summary Lidds AB (Lidds) is a developer of pharmaceutical products for the treatment of cancer and other diseases. The company offers Liproca Depot, an injectable product used for the treatment of prostate cancer. Its Liproca is a bioresorbable, biocompatible and locally injectable modified release …
  • Hospira Inc:医療機器:M&Aディール及び事業提携情報
    Summary Hospira Inc (Hospira), a subsidiary of Pfizer Inc, is a medical device company that offers injectable drugs and infusion technologies. The company offers products such as generic acute-care and oncology injectables, biosimilars, infusion systems, IV sets, IV safety devices, biosimilars, diff …
  • Symic Biomedical Inc-製薬・医療分野:企業M&A・提携分析
    Summary Symic Biomedical Inc (Symic Biomedical) is a biopharmaceutical company that develops library of compounds that target and protect the ECM (extracellular matrix) from illness or injury-related degradation. The company’s ECM specific compounds facilitate local application, which enhances its a …
  • Biotest AG (BIO):企業の財務・戦略的SWOT分析
    Biotest AG (BIO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Amyris Inc (AMRS):企業の財務・戦略的SWOT分析
    Summary Amyris Inc (Amyris) formerly Amyris Biotechnologies Inc, is a healthcare product manufacturer that offers integrated renewable products. The company provides alternatives to a range of petroleum-sourced products and rare materials. It offers health and wellness products, clean beauty product …
  • Global Voice Group SA:企業の戦略的SWOT分析
    Global Voice Group SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Tianjin Chase Sun Pharmaceutical Co Ltd (300026):企業の財務・戦略的SWOT分析
    Summary Tianjin Chase Sun Pharmaceutical Co Ltd (Chase Sun) is a medicine and health industry group. The company research, develops, produces, and markets various pharmaceutical products. It offers products such as Chinese herb preparations, Chinese medicinal granules, synthetic drugs, biotech drugs …
  • Pulmonx Corp:医療機器:M&Aディール及び事業提携情報
    Summary Pulmonx Corp (Pulmonx) is a medical device company that manufactures and markets minimally invasive medical devices and technologies for the diagnosis and treatment of pulmonary disorders. The company uses combination of assessment tools and therapeutics which enables physicians to successfu …
  • Banca Carige SpA (CRG):企業の財務・戦略的SWOT分析
    Banca Carige SpA (CRG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Zain Group:企業の戦略・SWOT・財務分析
    Zain Group - Strategy, SWOT and Corporate Finance Report Summary Zain Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Ocean Rig UDW Inc (ORIG):企業の財務・戦略的SWOT分析
    Summary Ocean Rig UDW Inc (Ocean Rig), formerly Primelead Shareholders Inc is an offshore drilling contractor that offers oilfield services. The company owns and operates 13 offshore ultra deepwater drilling units including ultra deepwater semi submersible drilling rigs, and ultra deepwater drillshi …
  • Aesica Pharmaceuticals Ltd:企業の戦略的SWOT分析
    Aesica Pharmaceuticals Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • GENTEX Corp:企業の戦略的SWOT分析
    GENTEX Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • SPR Therapeutics LLC:製品パイプライン分析
    Summary SPR Therapeutics LLC (SPR Therapeutics) is a medical device company that develops and commercializes neurostimulation based therapies and medical devices. The company develops and commercializes therapies for post-surgical pain, neuropathic pain, and musculoskeletal pain. It also provides pe …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆